FONAR Board of Directors Appoints Independent Director
FONAR Corporation (NASDAQ: FONR), known for inventing MR Scanning, has appointed Robert M. Carrino as an independent director to its board, replacing retiring director Claudette J.V. Chan. The company's subsidiary, Health Management Company of America (HMCA), currently manages 44 MRI scanners in New York and Florida, performing over 200,000 MRI scans annually.
Carrino, a partner at CFGI, LLC in New York City, brings extensive public accounting experience and leads the firm's SPAC practice. His appointment is particularly significant as FONAR transitions into accelerated filer status. Previously, Carrino served as an audit manager at KPMG, LLP and holds a Bachelor of Science in Business Administration with an accounting concentration.
FONAR Corporation (NASDAQ: FONR), nota per aver inventato la risonanza magnetica, ha nominato Robert M. Carrino come direttore indipendente nel suo consiglio di amministrazione, in sostituzione della direttrice in pensione Claudette J.V. Chan. La controllata dell'azienda, Health Management Company of America (HMCA), gestisce attualmente 44 scanner MRI a New York e in Florida, effettuando oltre 200.000 esami MRI all'anno.
Carrino, partner presso CFGI, LLC a New York City, vanta una vasta esperienza nella contabilità pubblica e guida la pratica SPAC della società. La sua nomina è particolarmente rilevante poiché FONAR sta passando allo status di accelerated filer. In precedenza, Carrino ha lavorato come audit manager presso KPMG, LLP e possiede una laurea in Business Administration con specializzazione in contabilità.
FONAR Corporation (NASDAQ: FONR), conocida por inventar la resonancia magnética, ha nombrado a Robert M. Carrino como director independiente en su junta directiva, en reemplazo de la directora retirada Claudette J.V. Chan. La subsidiaria de la empresa, Health Management Company of America (HMCA), actualmente administra 44 escáneres de resonancia magnética en Nueva York y Florida, realizando más de 200,000 escaneos de resonancia magnética anualmente.
Carrino, socio en CFGI, LLC en la ciudad de Nueva York, aporta una amplia experiencia en contabilidad pública y lidera la práctica SPAC de la firma. Su nombramiento es especialmente significativo ya que FONAR está en proceso de transición a un estado de presentador acelerado (accelerated filer). Anteriormente, Carrino trabajó como gerente de auditoría en KPMG, LLP y posee una licenciatura en Administración de Empresas con concentración en contabilidad.
FONAR Corporation (NASDAQ: FONR)는 MRI 스캐닝을 발명한 회사로 알려져 있으며, 은퇴하는 이사 Claudette J.V. Chan을 대신하여 Robert M. Carrino를 독립 이사로 이사회에 선임했습니다. 회사의 자회사인 Health Management Company of America (HMCA)는 현재 뉴욕과 플로리다에서 44대의 MRI 스캐너를 운영하며 연간 20만 건 이상의 MRI 스캔을 수행하고 있습니다.
뉴욕시의 CFGI, LLC 파트너인 Carrino는 풍부한 공공 회계 경험을 보유하고 있으며 회사의 SPAC 업무를 이끌고 있습니다. 그의 선임은 FONAR가 가속 신고자(accelerated filer)로 전환하는 시점에서 특히 중요합니다. 이전에는 KPMG, LLP에서 감사 매니저로 근무했으며 회계 전공의 경영학 학사 학위를 보유하고 있습니다.
FONAR Corporation (NASDAQ: FONR), reconnue pour avoir inventé la technologie IRM, a nommé Robert M. Carrino administrateur indépendant au sein de son conseil d'administration, en remplacement de la directrice Claudette J.V. Chan qui prend sa retraite. La filiale de l'entreprise, Health Management Company of America (HMCA), gère actuellement 44 scanners IRM à New York et en Floride, réalisant plus de 200 000 examens IRM par an.
Carrino, associé chez CFGI, LLC à New York, possède une vaste expérience en comptabilité publique et dirige la pratique SPAC de la société. Sa nomination est particulièrement importante alors que FONAR passe au statut de déclarant accéléré (accelerated filer). Auparavant, Carrino a été manager d'audit chez KPMG, LLP et détient un Bachelor of Science en administration des affaires avec une spécialisation en comptabilité.
FONAR Corporation (NASDAQ: FONR), bekannt als Erfinder der MRT-Technologie, hat Robert M. Carrino als unabhängiges Vorstandsmitglied berufen und ersetzt damit die ausscheidende Direktorin Claudette J.V. Chan. Die Tochtergesellschaft des Unternehmens, Health Management Company of America (HMCA), betreibt derzeit 44 MRT-Scanner in New York und Florida und führt jährlich über 200.000 MRT-Untersuchungen durch.
Carrino, Partner bei CFGI, LLC in New York City, bringt umfassende Erfahrung in der Wirtschaftsprüfung mit und leitet die SPAC-Praxis der Firma. Seine Ernennung ist besonders bedeutsam, da FONAR den Status eines beschleunigten Berichtspflichtigen (accelerated filer) erreicht. Zuvor war Carrino als Audit Manager bei KPMG, LLP tätig und besitzt einen Bachelor of Science in Betriebswirtschaft mit Schwerpunkt Rechnungswesen.
- None.
- None.
Melville, New York--(Newsfile Corp. - July 2, 2025) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning, today announced that on July 2, 2025, its board of directors appointed Mr. Robert M. Carrino as an independent director of the Company's board of directors. This appointment fills a vacancy on the board left by Ms. Claudette J.V. Chan, who recently retired from her position. The Company is very grateful for Ms. Chan's years of service and loyalty to FONAR.
Timothy Damadian, chairman and CEO of FONAR, said, "Our primary source of income and growth is attributable to our diagnostic imaging management subsidiary, Health Management Company of America (HMCA). In 2009, HMCA managed 9 MRI scanners; today it manages 44 MRI in New York and Florida that collectively complete over 200,000 MRI scans per year. We are proud of the success of HMCA and are committed to see it grow for years to come."
Mr. Damadian continued, "Mr. Carrino's extensive public accounting experience will be a tremendous asset to our organization. His nine years at CFGI, the leading global independent accounting and business advisory firm, which provides consulting services for various industries, including healthcare, will be helpful to us as we take initiatives to improve our business. His accounting expertise will be an invaluable resource as FONAR is transitioning into accelerated filer status. We are very fortunate to have Mr. Carrino on FONAR's board of directors and we look forward to working with him."
Mr. Carrino is a partner at CFGI, LLC in New York City, where he leads the firm's SPAC practice. He provides complex accounting and consulting services to both public and private companies. Prior to joining CFGI, Mr. Carrino was an audit manager at KPMG, LLP's Metro New York Long Island Office. Mr. Carrino, a Certified Public Accountant, earned the degree of Bachelor of Science in Business Administration with a concentration in accounting from Western New England University.
About FONAR
FONAR, The Inventor of MR Scanning™, located in Melville, NY, was incorporated in 1978, and is the first, oldest and most experienced MRI Company in the industry. FONAR went public in 1981 (Nasdaq:FONR). FONAR sold the world's first commercial MRI to Ronald J. Ross, MD, Cleveland, Ohio. It was installed in 1980. Dr. Ross and his team began the world's first clinical MRI trials in January 1981. The results were reported in the June 1981 edition of Radiology/Nuclear Medicine Magazine and the April 1982 peer-reviewed article in the Journal Radiology. The technique used for obtaining T1 and T2 values was the FONAR technique (Field fOcusing Nuclear mAgnetic Resonance), not the back projection technique. www.fonar.com/innovations-timeline.html.
FONAR's signature product is the FONAR UPRIGHT® Multi-Position™ MRI (also known as the STAND-UP® MRI), the only whole-body MRI that performs Position™ Imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® Multi-Position™ MRI often detects patient problems that other MRI scanners cannot because they are lie-down, "weightless-only" scanners. The patient-friendly UPRIGHT® MRI has a near-zero patient claustrophobic rejection rate. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately
FONAR has new works-in-progress technology for visualizing and quantifying the cerebral hydraulics of the central nervous system, the flow of cerebrospinal fluid (CSF), which circulates throughout the brain and vertebral column at the rate of 32 quarts per day. This imaging and quantifying of the dynamics of this vital life-sustaining physiology of the body's neurologic system has been made possible first by FONAR's introduction of the MRI and now by this latest works-in-progress method for quantifying CSF in all the normal positions of the body, particularly in its upright flow against gravity. Patients with whiplash or other neck injuries are among those who will benefit from this new understanding.
FONAR's primary source of income and growth is attributable to its wholly-owned diagnostic imaging management subsidiary, Health Management Company of America (HMCA) www.hmca.com.
FONAR's substantial list of patents includes recent patents for its technology enabling full weight-bearing MRI imaging of all the gravity sensitive regions of the human anatomy, especially the brain, extremities and spine. It includes its newest technology for measuring the Upright cerebral hydraulics of the cerebrospinal fluid (CSF) of the central nervous system. FONAR's UPRIGHT® Multi-Position™ MRI is the only scanner licensed under these patents.
#
UPRIGHT®, and STAND-UP® are registered trademarks. The Inventor of MR Scanning™, CSP™, MultiPosition™, UPRIGHT RADIOLOGY™, pMRI™, CFS Videography™, Dynamic™ and The Proof is in the Picture™, are trademarks of FONAR Corporation.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.
Contact: Daniel Culver
Director of Communications
E-mail: investor@fonar.com
www.fonar.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/257595
FAQ
Who is the new independent director appointed to FONAR's (NASDAQ: FONR) board?
How many MRI scanners does FONAR's HMCA subsidiary currently manage?
What is Robert Carrino's professional background before joining FONAR's board?
How has FONAR's HMCA subsidiary grown since 2009?
Why did FONAR appoint a new independent director?
